A carregar...
Phase I trial of the novel taxane BMS-184476 administered in combination with carboplatin every 21 days
The aim of the study was to determine the maximum-tolerated dose and dose-limiting toxicities for BMS-184476, in combination with carboplatin, in patients with advanced solid tumours and to describe any preliminary antitumour activity associated with this regimen. Patients received combination thera...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2409820/ https://ncbi.nlm.nih.gov/pubmed/15213727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601885 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|